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Disulfide-bonded forms of collagen VI were analyzed by ~mmunoblotting of tibroblast culture medium and 
cell extracts. The protein consists of pepsin and collagenase-resistant domains of about equal size indicating 
a molecular mass of 340 kDa for collagen VI monomers. 
Micrqfibrillar collagen VI Immunoblotting 
1. INTRODUCTION 
Collagen VI has been recently identified as a 
particular type of collagenous protein which forms 
microfibrils and cross-banded fibers with 1OOnm 
periodicity in tissues and cell cultures [l-4]. It 
shows ubiquitous tissue distribution [2,5,6] and 
was originally discovered as a pepsin-resistant 
fragment obtained from aortic intima 171. These 
pepsin fragments consist of a 105 nm long triple 
helical domain with globular domains at each end 
which are folded from 3 chain fragments of M,= 
40 000-70 000 [ 1 J-lo]. The dumbbell-like mono- 
mers are usually assembled into dimers, tetramers 
and larger associates which are cross-linked by 
disulfide bonds [I]. The application of non-de- 
grading extraction conditions led more recently to 
the chemical and immunological characterization 
of llO-140-kDa chains which are presumably the 
constituents of genuine tissue forms of collagen VI 
[2,6,1 l-161. These genuine structures have the 
same dumbbell-like shape as found for pepsin- 
treated monomers and oligomers except for a dis- 
tinctly larger size of both terminal globular do- 
mains [2,13]. 
Collagen VI is synthesized by fibroblasts and 
some other connective tissue cells. The chains of 
newly synthesized collagen VI are identical to or 
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slightly larger in size than those found in tissues 
[2,6,12,14]. Controversial data exist about the 
nature of the globular domains, which have been 
reported to be of different size classes [141 or to be 
completely degraded by bacterial collagenase [151. 
Since both sets of data are not compatible with 
structural data obtained for tissue forms of col- 
lagen [2,13] they prompted us to reexamine the do- 
main structure of fibroblast-derived collagen VI. 
2. MATERIALS AND METHODS 
Fibroblast cultures from human embryonic or 
adult skin (4th to 10th passage) were grown to con- 
fluency in Dulbecco’s modified Eagle’s medium 
supplemented with sodium ascorbate (50pgfml), 
glutamine (300fig/ml), penicillin (400 units/ml), 
streptomycin (50pg/ml) and 10% fetal calf serum 
[17]. Medium was then collected from a 24 h in- 
cubation in the absence of serum. Cell layers were 
extracted with phosphate-buffered saline pH 7.2 
by freeze-thawing and the insoluble pellet was ex- 
tracted (18 h, 20°C) with 0.01 M cysteine, pH 7.2. 
Protease inhibitors (OS mM phenylmethane-sul- 
fonyl fluoride, 0.1 mM p-hydroxymercuribenzoate) 
were added to the medium and the cell extract. 
Proteins of the medium and cell extract were 
concentrated by precipitation with 30% saturated 
ammonium sulfate (fractions M-30 and C-30, res- 
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pectively), precipitates were collected by centri- 
fugation (12 000 rpm, 1 h), dissolved in a small 
volume of 0.5 M NaCl, 0.05 M Tris-HCl, pH 7.4, 
and after dialysis against the same buffer stored 
at -20°C. A second fraction (M-80) was ob- 
tained from the medium by raising the ammonium 
sulfate concentration to 80% saturation. Aliquots 
of these samples were dialyzed against 0.5% acetic 
acid adjusted to pH 2, and digested with pepsin 
(0.1 mg/ml) for 18 h at 4°C. The reaction was 
stopped by adding pepstatin (0.2 mg/ml) and 
neutralization with Tris base. After addition of 
50 mM CaCl2 and 2.5 mM N-ethylmaleimide other 
aliquots were digested with l~g/ml purified bac- 
terial collagenase (kindly given by Dr B. Peterkof- 
sky 1181) for 3-24 h at 37°C. The reaction was 
stopped by adding electrophoresis ample buffer 
and boiling (3 min). Collagenase digests were pre- 
pared from non-reduced samples and samples 
which were reduced with either 0.02 M 2-mercapto- 
ethanol or 0.02M dithiothreito1 (4 h, room tem- 
perature) followed by aikylation with 0.08 M 
iodoacetamide for 2 h. Reagents were removed by 
dialysis. Control experiments without added en- 
zymes revealed no change of the size of collagen VI 
chains as shown by immunoblotting. 
Proteins were separated by polyacryl~ide gel 
electrophoresis in the presence of SDS fl9] prior to 
and after reduction with 5% 2-mercaptoethanol. 
They were then transferred to nitrocellulose [20] 
and collagen VI antigens were visualized by im- 
munoblotting 1211. In some cases transfers were 
done after incubating the gels in 0.01 M dithio- 
threitol, pH 8.6 (1 h, room temperature). Affinity- 
purified rabbit antibodies against pepsin-treated 
collagen VI from human placenta [2] were used at 
a concentration of IS-35pg/ml in the immunoblot 
reaction. Runs were calibrated with a collagen I 
standard and pepsin-treated collagen VI [lo] and 
as non-collagenous markers with myosin, ,&galac- 
tosidase, phosphorylase b, serum albumin, ovalbu- 
min, carbonic anhydrase, soybean trypsin in- 
hibitor and lysozyme obtained from Bio-Rad. 
Medium proteins were separated by sucrose 
gradient centrifugation [22] in the presence of i2?- 
labelled laminin [23] as internal marker. The frac- 
tions were analyzed for procollagen III by radioim- 
munoassay [24] and for collagen VI by immuno- 
dotting and after reduction and electrophoresis by 
immunoblotting. 
500 
3. RESULTS 
Collagen VI antigen could be detected by im- 
munoblotting in fibroblast culture medium only 
after concentrating it 50-lOO-fold by ammonium 
sulfate precipitation. Medium fraction M-30 (O- 
30% ammonium sulfate) showed a single band 
after reduction (140 kDa according to globular 
standards) which as shown previously [2] co- 
migrated with non-degraded collagen VI chains in 
tissue extracts. A double band of similar mobility 
was observed in the cell extracts obtained with or 
without cyteine (C-30). These samples showed no 
reaction or only a weak positive one when analyzed 
prior to reduction (fig.1 and 2). The medium frac- 
tion M-80 (30-80~0 ~monium sulfate) showed 
already prior to reduction a major 140-kDa band 
and in addition a component with the migration of 
a dimer (&component). The latter was converted 
to the monomers by reduction (fig.1). 
Disulfide bonding of M-30 components was 
studied by electrophoresis under non-reducing 
conditions followed by exposure to dithiothreitol 
prior to the transfer to nitrocellulose. Antibody 
staining then revealed a strong band on top of the 
Fig. 1. Identification by immunoblotting of non-de- 
graded (a) and pepsin-treated (b) forms of collagen VI 
produced by fibroblasts. The collagens were 
SO-100-fold concentrated by precipitation with am- 
monium sulfate from culture medium (M-30, O-30% 
saturation; M-80, 30-80% saturation) and from NaCl 
extracts of cells (C-30) and separated prior to f-ME) or 
after (+ ME) reduction with 2-mercaptoethanol on 
5-10070 polyacrylamide gradient gels. Positions of col- 
lagen I markers (al) and cu2 chains, &components) and 
of pepsin-treated collagen VI (P) are indicated by 
arrows. 
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gel indicating that the large size of the antigen had 
presumably prevented its efficient transfer to 
nitrocellulose prior to reduction. Treatment of 
fraction M-80 in the same way failed to demon- 
strate collagen VI antigens of high Mr. Separation 
of M-30 proteins by sucrose gradient centrifuga- 
tion demonstrated cosedimentation of collagen VI 
with the added laminin marker which both ap- 
peared larger than procollagen III determined in 
the fractions by radioimmunoassay. Reduction of 
the collagen VI peak fraction produced the 140- 
kDa band on gel electrophoresis as found for the 
whole medium. 
Treatment of fractions M-30 and C-30 with pep- 
sin degraded the collagen VI antigen to one or two 
components which have the same mobility as the 
major bands of pepsin-treated collagen VI ob- 
tained from tissue samples (fig.lb). This indicates 
an A4, of about 40000 for the fragments [8-lo] 
which contain mainly the triple helical domain of 
collagen VI. The collagen VI component in frac- 
tion M-80 was entirely degraded by pepsin since no 
antigen bands could be detected by immunoblot- 
ting (fig. lb). 
loxgel 7%gel 
OMD OMD OMD 
-67 
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Fig.2. Immunoblot reaction of collagen VI domains 
resistant against bacterial collagenase. Materials were 
not reduced (0) or reduced with 0.02M 2-mercapto- 
ethanol (M) or with 0.02M dithiothreitol (D) prior to 
treatment with collagenase for 3 h (10% gel) or 24 h (7% 
gel) and were compared to non-treated controls. The 7% 
gel run was aimed to show intermediary cleavage pro- 
ducts and major fragments (below 50 kDa) have already 
run out from the gel. All separations were calibrated 
with globular marker proteins and their migration posi- 
tions are labelled by their molecular masses given in 
kDa. 
As expected from previous studies [ 191 digestion 
of collagen VI in fraction M-30 with bacterial col- 
lagenase was dependent on the partial or complete 
opening of disulfide bridges in the protein. Treat- 
ment with 0.02 M 2-mercaptoethanol r more effi- 
ciently with 0.02M dithiothreitol allowed the 
degradation to a major doublet band with an 
average M,= 37 000 according to globular stan- 
dards (fig.2). In addition mercaptoethanol-treated 
but not dithiothreitol-treated samples still con- 
tained a major lOO-kDa band and some non- 
degraded 140-kDa material. The latter sample also 
showed a minor 42-kDa band which, however, was 
lost after a second reduction. Similar fragments 
but with much lower intensity were observed in 
collagenase-digests of non-reduced collagen VI. 
4. DISCUSSION 
We have recently characterized antibodies 
against pepsin-solubilized collagen VI from human 
placenta which react with collagenous and non- 
collagenous epitopes of all constituent chains of 
the antigen [2]. These antibodies were therefore 
suited for the domain analysis of intact collagen VI 
and demonstrated a single or two peptide chains in 
culture medium and cell layer extracts of skin 
fibroblasts. These peptide chains comprise in 
mobility collagen VI material characterized in 
other cell cultures [6,12,15] but are smaller than 
those found in bovine fibroblasts [ 141. The peptide 
chains of fibroblast collagen VI are connected by 
disulfide bonds to larger complexes as shown by 
electrophoresis and sedimentation analysis. Most 
of the material sediments together with laminin 
(.s%,~ =11.5 S; M, about 1000 000) and before pro- 
collagen III (.s%,~ =4.2 S; M, = 450 000) indicating 
that it consists of collagen VI tetramers or larger 
aggregates [ 11. Filamentous aggregates resembling 
collagen VI structures have been recently demon- 
strated in fibroblast cultures [3]. 
In addition, fibroblast medium contained smaller 
collagen VI components (fraction M-80) similar to 
those which have been isolated with monoclonal 
antibodies [6]. This material apparently consisted 
of non-triple helical monomeric and dimeric pep- 
tide chains which could be completely destroyed by 
pepsin treatment. 
Collagen VI from fibroblasts possesses dis- 
tinct collagenase-resistant peptide segments (Mr = 
501 
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37 000) which are larger than those found in 
pepsin-treated collagen VI [lo] and require reduc- 
tion of disulfide bonds for their proper release. 
They very likely are the constituents of the two 
globular domains seen at each end of genuine col- 
lagen VI by electron microscopy [2,13]. These non- 
collagenous peptides showed a limited electro- 
phoretic heterogeneity which could be due to their 
origin from different chains or different ends of 
the molecule. A collagenase-resistant peptide with 
Mr= 38 000 but also two larger components (M,= 
65 000 and M,= 76 000) have been described for 
reduced and alkylated collagen VI chains from 
bovine aorta [13]. Even larger fragments (M,= 
100000) were found after treating non-reduced 
collagen VI with collagenase [ 141 and, as shown by 
our data, are presumably incompletely cleaved 
fragments. Complete cleavage is prevented by the 
formation of collagen VI oligomers which stabi- 
lizes the overlapping triple helical segments [l, lo]. 
Still another study [15] failed to identify large 
fragments in colagenase digests of reduced col- 
lagen VI. Since these data are incompatible with 
the presence of distinct globular domains in col- 
lagen VI they could reflect the lack of some an- 
tisera to react with these structures in immuno- 
blotting. 
Monomeric collagen VI has been visualized as a 
symmetric, dumbbell-shaped structure by rotary 
shadowing electron microscopy [2,13]. The data 
for the collagenase-resistant segments suggest an 
M, of about 110000 for each globular domain 
which together with M,= 120 000 for the triple 
helical domain [S-lo] adds up to M, = 340 000 for 
intact collagen VI. This value is within the range 
predicted from M, = 110 000-140 000 for the con- 
stituent chains [2,6,11- 13,15,16] and in agreement 
with electron microscopic data indicating an M, of 
about 150 000 for the globular domains [4]. The 
data do not support a structural model for collagen 
VI consisting of two globular domains of distinctly 
different size [ 141. 
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